THE PLACEBO-EFFECT IN HEALTHY-VOLUNTEERS - INFLUENCE OF EXPERIMENTAL CONDITIONS ON THE ADVERSE EVENTS PROFILE DURING PHASE-I STUDIES

Citation
P. Rosenzweig et al., THE PLACEBO-EFFECT IN HEALTHY-VOLUNTEERS - INFLUENCE OF EXPERIMENTAL CONDITIONS ON THE ADVERSE EVENTS PROFILE DURING PHASE-I STUDIES, Clinical pharmacology and therapeutics, 54(5), 1993, pp. 578-583
Citations number
13
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00099236
Volume
54
Issue
5
Year of publication
1993
Pages
578 - 583
Database
ISI
SICI code
0009-9236(1993)54:5<578:TPIH-I>2.0.ZU;2-Y
Abstract
In contrast to the plethora of publications on placebo effects in pati ents, very tittle is known about placebo effects in healthy volunteers during clinical pharmacology studies. We therefore reviewed the adver se events spontaneously reported during placebo administration in 109 double-blind, placebo-controlled studies involving 1228 volunteers. Th e overall incidence of adverse events in the healthy volunteers during placebo administration was 19%. As expected, complaints were more fre quent after repeated dosing (28%) and in elderly subjects (26%). Overa ll, the most frequent adverse events were headache (7%), drowsiness (5 %), and asthenia (4%), with some variation depending on study design a nd population. In conclusion, these data shed new light on the impact of experimental conditions on the results of safety evaluations in hea lthy volunteers participating in clinical pharmacology studies.